|
|
Home
The Word Brain
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
| Prostate Cancer |
|
Free Subscription
3 BJU Int |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Prostate Cancer is free of charge.
Added value of randomised biopsy to multiparametric magnetic resonance
imaging-targeted biopsy of the prostate in a contemporary cohort.
BJU Int. 2024;133:548-554.
PubMed
Abstract available
Complications of immuno-oncology care: what urologist should know.
BJU Int. 2024;133:524-531.
PubMed
Abstract available
Peri-operative outcomes following radical prostatectomy in the setting of
advanced prostate cancer.
BJU Int. 2024 Apr 23. doi: 10.1111/bju.16370.
PubMed
Abstract available
Creatine supplementation and resistance training to preserve muscle mass and
attenuate cancer progression (CREATINE-52): a protocol for a double-blind
randomized controlled trial.
BMC Cancer. 2024;24:493.
PubMed
Abstract available
The effects of different positions on lower extremity hemodynamics during
robot-assisted laparoscopic radical prostatectomy for prostate cancer.
BMC Urol. 2024;24:92.
PubMed
Abstract available
ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth
and constrain ferroptosis.
Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-1489.
PubMed
Abstract available
Correction to: Surgical Management and Considerations for Patients with Localized
High-Risk Prostate Cancer.
Curr Treat Options Oncol. 2024 Apr 20. doi: 10.1007/s11864-024-01208.
PubMed
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Eur Radiol. 2024 Apr 24. doi: 10.1007/s00330-024-10770.
PubMed
Abstract available
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen
Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for
Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer:
Analyses of
Eur Urol. 2024 Apr 20:S0302-2838(24)02264-4. doi: 10.1016/j.eururo.2024.
PubMed
Abstract available
Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering
[(177)Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk
Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2
Study. Eur Urol. In press.
Eur Urol. 2024 Apr 20:S0302-2838(24)02310-8. doi: 10.1016/j.eururo.2024.
PubMed
Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al.
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the
Age of 45 Years: Results from the First Screening Round of the PROBASE Trial. Eur
Urol 2024;85:105-11
Eur Urol. 2024 Apr 20:S0302-2838(24)02315-7. doi: 10.1016/j.eururo.2024.
PubMed
Metabolic characterization of sphere-derived prostate cancer stem cells reveals
aberrant urea cycle in stemness maintenance.
Int J Cancer. 2024 Apr 22. doi: 10.1002/ijc.34967.
PubMed
Abstract available
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a
Prospective Study With 7.2 Years of Follow-Up.
J Clin Oncol. 2024 Apr 23:JCO2301391. doi: 10.1200/JCO.23.01391.
PubMed
Abstract available
Prospective Comparison of (68)Ga-NeoB and (68)Ga-PSMA-R2 PET/MRI in Patients with
Biochemically Recurrent Prostate Cancer.
J Nucl Med. 2024 Apr 25:jnumed.123.267017. doi: 10.2967/jnumed.123.267017.
PubMed
Abstract available
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive
Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer
(PSMA-dRT Trial).
J Nucl Med. 2024 Apr 25:jnumed.123.267004. doi: 10.2967/jnumed.123.267004.
PubMed
Abstract available
HistoEM: A Pathologist-Guided and Explainable Workflow Using Histogram Embedding
for Gland Classification.
Mod Pathol. 2024;37:100447.
PubMed
Abstract available
Alternative splicing in prostate cancer progression and therapeutic resistance.
Oncogene. 2024 Apr 24. doi: 10.1038/s41388-024-03036.
PubMed
Abstract available
Real-world utilization, patient characteristics, and treatment patterns among men
with localized prostate cancer tested with the 17-gene genomic prostate score(R)
(GPS(TM)) assay.
Prostate. 2024 Apr 26. doi: 10.1002/pros.24709.
PubMed
Abstract available
Molecular analysis of archival diagnostic prostate cancer biopsies identifies
genomic similarities in cases with progression post-radiotherapy, and those with
de novo metastatic disease.
Prostate. 2024 Apr 23. doi: 10.1002/pros.24715.
PubMed
Abstract available
Translation and validation of a lifestyle questionnaire related to prostate
cancer.
Prostate. 2024 Apr 21. doi: 10.1002/pros.24713.
PubMed
Abstract available
Association of PARP inhibitor treatment on the prevalence and progression of
clonal hematopoiesis in patients with advanced prostate cancer.
Prostate. 2024 Apr 20. doi: 10.1002/pros.24712.
PubMed
Abstract available
Combination of prostate volume and apparent diffusion coefficient can stratify
patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies.
Prostate. 2024;84:780-787.
PubMed
Abstract available
Key learnings from concordant systematic biopsies in prostate-specific membrane
antigen positron emission tomography/computed tomography-guided prostate
biopsies: Enhancing targeting accuracy.
Prostate. 2024;84:772-779.
PubMed
Abstract available
Cumulative cancer locations on prostate biopsy and active surveillance outcomes
in the MRI era.
Prostate. 2024;84:723-730.
PubMed
Abstract available
Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use
criteria in a large network system.
Prostate. 2024;84:717-722.
PubMed
Abstract available
Advances in Tumor Management: Harnessing the Potential of Histotripsy.
Radiol Imaging Cancer. 2024;6:e230159.
PubMed
Abstract available
Editorial Comment on "Major Complications and Adverse Events Related to use of
SpaceOAR Hydrogel for Prostate Cancer Radiotherapy".
Urology. 2024 Apr 20:S0090-4295(24)00274-7. doi: 10.1016/j.urology.2024.
PubMed
Thank you for your interest in scientific medicine.
